Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The capsular polysaccharides of Neisseria meningitidis are complex carbohydrate polymers that form the outermost protective layer of the bacterium. These polysaccharides are the primary determinants of the 12 different serogroups of N. meningitidis and serve as critical virulence factors by allowing the pathogen to evade host immune responses, such as complement-mediated killing (Stephens et al., 2007). Serogroups A, C, Y, W-135, and X are globally significant as they are responsible for the majority of invasive meningococcal disease cases, including life-threatening meningitis and septicemia (WHO, 2023). In pharmaceutical development, these polysaccharides are utilized as antigens in vaccines to induce protective immunity. Modern conjugate vaccines chemically link these polysaccharides to carrier proteins to enhance immunogenicity and induce long-term immunological memory (Pollard et al., 2009). Upon vaccination, the immune system produces specific antibodies that recognize these polysaccharides, leading to the destruction of the bacteria through opsonization and complement activation (Borges et al., 2019).
Induction of a humoral immune response where the polysaccharides act as antigens to stimulate the production of serogroup-specific bactericidal antibodies, facilitating complement-mediated lysis and opsonophagocytosis of Neisseria meningitidis.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Capsular polysaccharides of Neisseria meningitidis serogroups A, C, Y, W-135, and X (MenACWYX).